Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PFE
10. TSLA

Go back to Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
StemCells, Inc. (NASDAQ: TEM) Delayed: 49.62 +1.77 (3.70%)
Previous Close $47.85    52 Week High $0.45 
Open $47.00    52 Week Low $0.37 
Day High $49.85    P/E N/A 
Day Low $46.68    EPS $-0.31 
Volume 3,416,135